No Data
Earnings Preview: Crinetics to Report Financial Results Post-market on November 12
$Crinetics(CRNX.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $Crinetics(CRNX.US)$ to post revenue of USD239.90K for 2024Q3,
Investors Might Be Losing Patience for Crinetics Pharmaceuticals' (NASDAQ:CRNX) Increasing Losses, as Stock Sheds 5.6% Over the Past Week
Crinetics Pharmaceuticals: Strong Buy Recommendation Driven by Best-in-Class Efficacy and Solid Financial Position
State Street Corp's Strategic Acquisition in Crinetics Pharmaceuticals
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
JonesTrading Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $71
No Data
No Data